Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
A mixture of: N,N-diethylpropane-1,3-diamine 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate; 2,2-iminodiethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate; 2-methylaminoethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate
EC number: 403-410-1 | CAS number: 114565-65-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
Direct Yellow 166 is an orange powder with a density of 1.38 g/cm3at 23 °C, which decomposes before melting. The molecular weight is about 767 g/mol. The vapour pressure is <0.0019 Pa at 25°C (extrapolated), the substance is soluble in water, and the log Pow is 0.19 at 25 °C (pH 9.1).
Referring to acute toxicity, guideline studies are available for the oral and the dermal route of exposure; the LD50 for oral and dermal toxicity was > 5000 mg/kg bw and > 2000 mg/kg bw, respectively. In both cases, neither mortality nor clinical symptoms could be evidenced. Particulary the acute dermal toxicity study provides evidence that no significant dermal absorption of Direct Yellow 166 has to be expected.
No study is available for inhalation toxicity, however, it could be demonstrated that the conduct of such a study is scientifically unjustified, since (1) the determination of the vapour pressure for Direct Yellow 166 as liquid or in an amorphous form had revealed that percentage of compound volatiles is about 6% at 25 to 100 °C, and (2) particle size distribution analysis had resulted in a mass median diameter (MMD) of 23.4 µm, with 7.2% of particles having a diameter < 4 µm; therefore, the majority of generated particles will not penetrate into the broncho-alveolar tract. Thus, due to these physicochemical characteristics and taking into account the low acute toxic potential of the substance as shown by the oral and dermal studies, the conduct of an acute inhalation study was judged not necessary, also with respect to animal welfare.
With regard to long-term exposure, a subacute oral 28-day toxicity guideline study with Wistar rats of both sexes, was conducted. The substance was administered by gavage at dose levels of 0, 50 (low dose), 200 (mid dose) and 1000 mg/kg bw/day (high dose). In the control and the high dose groups, the rats were assigned to toxicity and recovery testing subgroups. No mortality occurred. Orange discoloured feces seen in all high dose animals during the test period and during the first 3 days of recovery implies that the substance is excreted via feces. The discolouration was considered to be due to the staining properties of the substance, and discoloured feces also were described within an OECD 421 reproduction and developmental toxicity screening test conducted with the same substance. In the 28 days repeated dose study, reversible changes in haematological data reflecting slight anaemia as well as changes in some clinical chemical parameters indicative of stress induced metabolic adaptation due to the treatment clearly indicate that the test substance was systemically available in the animals.
Thus, taken together, the physico-chemical properties of the substance and the available toxicological data provide evidence that no significant dermal absorption of Direct Yellow 166 has to be expected, and that, when systemically bioavailable, the substance would most likely be subjected to metabolism in the liver, and excretion, mainly via feces and urine. Bioaccumulation seems to be rather improbable.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.